HOME › DRUGS › BROLUCIZUMAB
ACTIVE SUBSTANCE / INN

BROLUCIZUMAB

Brand name(s): Beovu
EMA LISTED
AUTHORISED
Wet Macular Degeneration
ACTIVE SUBSTANCE
Brolucizumab
REGULATORS
EMA
SPONSORS / MAH
Novartis Europharm Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BeovuNovartis Europharm LimitedAuthorised13/02/2020Wet Macular Degeneration

FULL INTELLIGENCE ON BROLUCIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →